Based on these observations, we concluded that gedatolisib inhibited cell cycle progression and DNA replication more effectively relative to the other PAM inhibitors evaluated, both in PTEN− and PTEN+ PC cell lines. This evidence concerns the gene PTEN and pachyonychia congenita.